Alexion’s Bell Notes The Changing Role Of Innovation In Regulatory Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO of the ultra-rare disease focused biotech spoke about the challenges of launching a drug for a relatively unknown disease and how innovation is playing an increasing role in R&D.